Irked by the reluctance of the Kerala government to appoint one state licensing authority (SLA) for Ayush sector, the Ayush drug manufacturers in Kerala will shut down their production units indefinitely from next month. Further, they will boycott the International Ayush Conclave to be organized by the state government in the second week of May in Kochi.
The delay in the appointment of SLA for Ayush sector has compounded the problems being faced by the Ayush industry for the last one year. The situation has led 800 big and small manufacturing units into operational crisis, and north Indian companies make attempts to dominate the traditional drug market in Kerala, industry sources allege.
Ayurveda Medicine Manufacturers’ Organization of India (AMMOI), the manufacturers’ body of Ayush drugs, has given circular to all its member-units to refrain from participating in the four-day exhibition-cum-seminar event.
“The situation is opening doors for north Indian companies to expand their presence and sales in Kerala. While they take advantage of the situation, the domestic companies in the state will suffer and in the end they all will vanish from the scene. At last, Ayush companies of the north will survive resulting shortage of homely produced drugs in Kerala and unemployment for thousands of skilled workers and trained scientists,” he pointed out.